Comparing visual acuity and retinal thickness in diabetic patients with retinopathy who receive HBOT versus those who receive standard care or a placebo treatment. The study would assess outcomes over a specified period, with data collected at regular intervals. By including such studies in your meta-analysis, you can evaluate the overall effectiveness of HBOT in managing diabetic retinopathy.